Molecular profiling of post-menopausal women with breast cancer on neoadjuvant endocrine therapy with tamoxifen or exemestane.
Phase of Trial: Phase II
Latest Information Update: 07 Jul 2014
At a glance
- Drugs Exemestane; Tamoxifen
- Indications Breast cancer
- Focus Biomarker; Therapeutic Use
- Acronyms MoNET
- 24 Feb 2011 Planned end date changed from 1 Jan 2010 to 1 May 2011 as reported by ISRCTN: Current Controlled Trials.
- 22 Feb 2011 Status changed from recruiting to completed, as reported by Current Controlled Trials.
- 20 Apr 2007 New trial record.